Oliver Life Sciences Search

Life Sciences

News & Trends

Vaccine shown to prevent recurrence of pancreatic cancerA new vaccine successfully eliminates traces of pancreatic cancer and prevents relapses in treated patients.

Exclusive: Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data showsNovo Nordisk spent nearly $500 million on U.S. advertising for its GLP-1 drugs Wegovy and Ozempic in the first nine months of 2025, more than double what Eli Lilly shelled out for its rival medicines, as the Danish drugmaker fought for market share, data seen by Reuters shows.

Why you shouldn’t say “this study is underpowered”Ensuring our critiques of power are relevant, clear, and based on good statistics

November 1, 2023

Tools like ChatGPT can personalize clinical trials tech — if companies avoid the pitfalls

September 23, 2023

Adlai, building on the ashes of Novartis' failure, raises $57.5M IPO to run phase 3 cancer trial

Page updated

Report abuse